Scribd Logo
Upload

Welcome to Scribd!

  • Flyer Sympo 2B

    Uploaded by

    Jumrah Khumairah
    5 views1 page
    The document summarizes a symposium discussing the evolution of SGLT2 inhibitors in heart failure treatment beyond just diabetes management. The symposium will take place on September 11, 2021 from 10:30-12:00 and discuss the cardiorenal burden in type 2 diabetes patients, approaches to managing heart failure in diabetes patients from prevention to therapy, and how SGLT2 inhibitors have progressed from being considered safe to use to providing benefits in cardiorenal patients. The moderator and three speakers are also listed.

    Original Description:

    Original Title

    FLYER SYMPO 2B

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document summarizes a symposium discussing the evolution of SGLT2 inhibitors in heart failure treatment beyond just diabetes management. The symposium will take place on September 11, 2021 from 10:30-12:00 and discuss the cardiorenal burden in type 2 diabetes patients, approaches to managing heart failure in diabetes patients from prevention to therapy, and how SGLT2 inhibitors have progressed from being considered safe to use to providing benefits in cardiorenal patients. The moderator and three speakers are also listed.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    5 views1 page

    Flyer Sympo 2B

    Uploaded by

    Jumrah Khumairah
    The document summarizes a symposium discussing the evolution of SGLT2 inhibitors in heart failure treatment beyond just diabetes management. The symposium will take place on September 11, 2021 from 10:30-12:00 and discuss the cardiorenal burden in type 2 diabetes patients, approaches to managing heart failure in diabetes patients from prevention to therapy, and how SGLT2 inhibitors have progressed from being considered safe to use to providing benefits in cardiorenal patients. The moderator and three speakers are also listed.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    DAY 1 : Symposium 2B

    “Evolution of SGLT2i in Heart Failure –


    Beyond T2D Management”
    10:30 – 12:00 11 September 2021

    MOVING FORWARD FOR CARDIORENAL PROTECTION!

    DR. dr. Idar Mappangara, dr. Wahyu Aditya, dr. Siti Elkana Nauli, DR. dr. Ria Bandiara,
    SpJP(K) SpJP SpJP(K) SpPD-KGH
    Moderator Speaker Speaker Speaker

    TOPIC SPEAKER
    1. ”The Burden in Cardiorenal in T2D Patients - The CaReMe dr. Wahyu Aditya, SpJP
    Approach”
    2. ”Heart Failure Management in T2D Patients: From Prevention dr. Siti Elkana Nauli, SpJP(K)
    to Therapy”
    3. “SGLT2i: From Being Safe to Use to Benefiting in Cardiorenal DR. dr. Ria Bandiara, SpPD-KGH
    Patients”

    You might also like